Remgro Ltd Ord (RMGOF) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

and welcome to the Realm Grow Limited interim results presentation. All participants will be in listen-only mode. There will be an opportunity to ask questions later during the conference. If you should need assistance during the call, please signal an operator by pressing star, then zero. Please note that this call is being recorded. I would now like to turn the conference over to Yanni Gironde. Please go ahead, sir. Welcome to our interim results presentation for the period ended 30 December 2023. Before we go into the detail of everything, I should forewarn you that today's results presentation will be longer than usual, given the corporate actions we've been executing on the last year and the need to provide you with some context of the numbers behind them and as well as the corporate actions that we've done. The outline of today's presentation has really three areas of focus. Firstly, I will give an overview of the salient features of our results for the period under review. This will include providing you with a recap of our key strategic priorities as communicated in our previous results presentation. I will then also give you a sense of our own assessment of the progress we have been made in delivering against these priorities. Secondly, I will then ask our CFO, Mr Neville Williams, to unpack in more detail our results for this interim period. Thirdly, in keeping in line with our new format from our last results in September, We will be then giving an update on some of our key investments, namely MediClinic, CIVH, RCL Foods and Rainbow Chicken. The CEO of MediClinic, Ronnie van den Merwe, together with his CFO, Jurgens Meijberg, will speak to the MediClinic's operating context, results and strategic priorities. Thereafter, I'll ask the CIVH chairperson, Becke...